SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

13 Feb 2023 Evaluate
The sales slipped to Rs. 3446.19 millions for the December 2022 quarter as against Rs. 3722.05 millions during the year-ago period.Net Profit of the company move down -41.58% to Rs. 125.67  millions from Rs. 215.11 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 226.34 millions from 331.75 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3446.19 3722.05 -7.41 10023.58 11068.24 -9.44 14492.67 11124.23 30.28
Other Income 11.87 26.90 -55.87 27.70 162.47 -82.95 102.35 117.74 -13.07
PBIDT 226.34 331.75 -31.77 649.10 1262.04 -48.57 1393.72 1241.47 12.26
Interest 5.50 7.47 -26.37 14.19 9.58 48.12 -73.66 17.88 -511.97
PBDT 220.84 324.28 -31.90 634.91 1252.46 -49.31 1467.38 1223.59 19.92
Depreciation 45.57 52.78 -13.66 133.92 163.75 -18.22 211.95 281.10 -24.60
PBT 175.27 271.50 -35.44 500.99 1088.71 -53.98 1255.43 942.49 33.20
TAX 49.60 56.39 -12.04 141.33 220.85 -36.01 244.81 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 24.83 0.00 0.00
PAT 125.67 215.11 -41.58 359.66 867.86 -58.56 1010.62 942.49 7.23
Equity 1022.27 899.59 13.64 1022.27 899.59 13.64 955.59 899.59 6.23
PBIDTM(%) 6.57 8.91 -26.31 6.48 11.40 -43.21 9.62 11.16 -13.83

Morepen Laboratories Share Price

41.35 -0.57 (-1.36%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×